Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Completed

A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer

NCT03371017

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Florida Cancer Specialists - Fort Myers (Broadway) Fort Myers, Florida, United States
  • Florida Cancer Specialists & Research Institute St. Petersburg, Florida, United States
  • The Valley Hospital Paramus, New Jersey, United States
  • Magee-Woman's Hospital Pittsburgh, Pennsylvania, United States
View all 124 locations
View Trial Details
Completed

Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001)

NCT03396445

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +15 more
Locations
  • University of South Alabama, Mitchell Cancer Institute ( Site 0020) Mobile, Alabama, United States
  • Florida Cancer Specialists ( Site 0002) Sarasota, Florida, United States
  • The West Clinic, P.C. ( Site 0021) Germantown, Tennessee, United States
  • FALP-UIDO ( Site 0502) Santiago, Region M. de Santiago, Chile
View all 18 locations
View Trial Details
Completed

Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours

NCT03620643

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +20 more
Locations
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • Royal Marsden NHS Foundation Trust London, United Kingdom
  • Guys and St Thomas NHS Foundation Trust London, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details
Completed

Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)

NCT03036488

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Virginia G. Piper Cancer Center Pharmacy - Scottsdale Healthcare ( Site 0089) Scottsdale, Arizona, United States
  • Arizona Oncology Associates PC- HOPE ( Site 8001) Tucson, Arizona, United States
  • Cedars Sinai Medical Center ( Site 0091) Los Angeles, California, United States
  • Pacific Cancer Care ( Site 0069) Monterey, California, United States
View all 193 locations
View Trial Details
Completed

A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors

NCT05082610

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +23 more
Locations
  • The City of Hope National Medical Center Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Smilow Cancer Hospital - Yale New Heaven Health New Haven, Connecticut, United States
View Trial Details
Completed

Cisplatin vs Paclitaxel for Triple Negative Breast Cancer

NCT01982448

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Indiana University- Simon Cancer Center Indianapolis, Indiana, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 20 locations
View Trial Details

Related conditions